SCHEMBL7372152

SCHEMBL7372152

NC(=NCl)Nc1cncc2cc(C(=O)NCC(=O)OC(=O)C(F)(F)F)ccc12

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.32
F2 P00734 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
HPGDS O60760 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367816 0.85 PTPRC (0.42) F2MEN1KMT2AHPGDS
SCHEMBL7369185 0.83 PLAU (0.36) F2
SCHEMBL7363404 0.79 DGAT2 (0.41) KMT2A
SCHEMBL7378246 0.79 CA1 (0.42)
SCHEMBL7374054 0.78 PLAU (0.38) F2
SCHEMBL7378754 0.75 PLAU (0.41) MEN1KMT2A
SCHEMBL7366299 0.72 PLAU (0.38)
SCHEMBL7375012 0.72 PLG (0.41) F2MEN1KMT2A
SCHEMBL6436657 0.72 KDM4E (0.38)
SCHEMBL7448814 0.72 SMN1; SMN2 (0.36) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242120-A2 COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE Pfizer Limited (GB) 2002-09-25 EP disclosed
WO-2001049309-A2 COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE PFIZER LIMITED (GB) 2001-07-12 WO disclosed
EP-1077945-A1 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2001-02-28 EP disclosed
WO-2000005214-A2 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2000-02-03 WO disclosed